Ramona Optics Raises $25M for Advanced Microscopy

Ramona Optics has raised new funding for a technology that sits beneath much of modern biology: the ability to image large numbers of cells and samples quickly.

What happened

The company raised a $25 million Series A led by ARCH Venture Partners, with participation from Stealthpoint Ventures and ND Capital.

Ramona builds microscopes designed to capture biological samples across larger areas and at higher throughput than conventional systems.

The new capital will support global expansion alongside additional engineering and commercial hires.

Why it matters

Biology is becoming increasingly data-intensive. Drug discovery, cell therapy and AI-driven research all depend on large, high-quality datasets, but generating those datasets can be limited by laboratory instrumentation.

Higher-throughput imaging can allow researchers to observe more cells, conditions and experiments in parallel, potentially reducing one of the physical bottlenecks in biological research.

That makes better microscopes relevant not just to hardware buyers but to companies building computational and AI systems on top of biological data.

The bigger picture

The AI-biology boom depends on measurement infrastructure. Models can only learn from the experiments scientists are able to run and observe. Companies such as Ramona therefore sit in an enabling layer beneath computational biology, where improvements in sensors and instrumentation can increase the amount of useful data available to every downstream analytical tool.